Connect with us
Merck MSD acquired Imago BioSciences and expects the deal to close in the first quarter of 2023. Novo Nordisk will invest €726 million (DKK 5.4 billion)...
Beyond the 27 EU countries, the pharmaceutical industry maintains its relevance in Switzerland and ranks as the country's second most exported non-agricultural product, followed by blood...
If this round is successfully completed, Mediquo would add its sixth operation of this size. In April 2021, Encomenda Smart Capital and Dozen Investments led a...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...
Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...
The new healthcare information and data environment that Europe intends to develop "will be the driving force behind healthcare research, the development of digital technologies and...
Reig Jofre reported a profit of €4.2 million between January and September 2022, 16% less than in the same period of 2021. The company justifies this...
Following these results, Almirall has confirmed its financial estimates for 2022. Investment in research and development (R&D) increased by 11.3% in the period, to €71.6 million...
Following the latest closing, all previous major investors in the Oltre III fund were confirmed, including the European Investment Fund (EIF), which participated in raising €30...
Arthex Biotech is a spin-off of the University of Valencia (UV). Incorporated in September 2019, the company has its focus on the development of a treatment...
 |
|
 |  |
 |
|